The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Intra–bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice
Abstract
Intractable autoimmune diseases in chimeric resistant MRL/lpr mice were treated by a new bone marrow transplantation (BMT) method consisting of fractionated irradiation, 5.5 Gy × 2, followed by intra–bone marrow (IBM) injection of whole bone marrow cells (BMCs) from allogeneic normal C57BL/6 (B6) mice (5.5 Gy × 2 + IBM). In MRL/lpr mice treated with this method, the number of donor-derived cells in the bone marrow, spleen, and liver rapidly increased (almost 100% donor-derived cells by 14 days after the treatment), and the number of donor-derived hemopoietic progenitor cells concomitantly increased. Furthermore, donor-derived stromal cells were clearly detected in the cultured bone pieces from MRL/lpr mice treated with 5.5 Gy × 2 + IBM. All the recipients thus treated survived more than 1 year (> 60 weeks after birth) and remained free from autoimmune diseases. Autoantibodies decreased to almost normal levels, and abnormal T cells (Thy1.2+/B220+/CD4−/CD8−) disappeared. Hematolymphoid cells were reconstituted with donor-derived cells, and newly developed T cells were tolerant to both donor (B6)-type and host (MRL/lpr)-type major histocompatibility complex determinants. Successful cooperation was achieved among T cells, B cells, and antigen-presenting cells when evaluated by in vitro antisheep red blood cell responses. These findings clearly indicate that this new strategy (IBM-BMT) creates the appropriate hemopoietic environment for the early recovery of hemopoiesis and donor cell engraftment, resulting in the complete amelioration of intractable autoimmune diseases in chimeric resistant MRL/lpr mice without recourse to immunosuppressants. This strategy would therefore be suitable for human therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sasazuki, T., Juji, T., Morishima, Y., Kinukawa, N., Kashiwabara, H., Inoko, H., Yoshida, T., Kimura, A., Akaza, T., Kamikawaji, N., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391701 · Cited by 526
Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice
Bachar-Lustig, E., Rachamim, N., Li, H.-W., Lan, F., & Reisner, Y. (1995) · Nature Medicine · doi:10.1038/nm1295-1268 · Cited by 322
Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.
Ikehara, S., Ohtsuki, H., Good, R. A., Asamoto, H., Nakamura, T., Sekita, K., Muso, E., Tochino, Y., Ida, T., & Kuzuya, H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7743 · Cited by 218
Self-citationIshida, T., Inaba, M., Hisha, H., Sugiura, K., Adachi, Y., Nagata, N., Ogawa, R., Good, R. A., & Ikehara, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.3119 · Cited by 191
Self-citationClearance of severe psoriasis after allogenic bone marrow transplantation.
Eedy, D. J., Burrows, D., Bridges, J. M., & Jones, F. G. (1990) · BMJ · doi:10.1136/bmj.300.6729.908 · Cited by 178
Rl, S. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82652-7 · Cited by 159
Ikehara, S., Yasumizu, R., Inaba, M., Izui, S., Hayakawa, K., Sekita, K., Toki, J., Sugiura, K., Iwai, H., & Nakamura, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3306 · Cited by 149
Self-citationNelson, J. L., Torrez, R., Louie, F. M., Choe, O. S., Storb, R. F., & Sullivan, K. M. (1997) · PubMed · Cited by 143
Long‐term outcome of autoimmune disease following allogeneic bone marrow transplantation
Snowden, J. A., Kearney, P., Kearney, A., Cooley, H. M., Grigg, A., Jacobs, P., Bergman, J., Brooks, P., & Biggs, J. C. (1998) · Arthritis & Rheumatism · Cited by 126
Hashimoto, F., Sugiura, K., Inoue, K., & Ikehara, S. (1997) · Blood · doi:10.1182/blood.v89.1.49 · Cited by 110
Self-citation
Cited by
Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche
Taichman, R. S. (2005) · Blood · doi:10.1182/blood-2004-06-2480 · Cited by 649
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
Shi, M., Li, J., Liao, L., Chen, B., Li, B., Chen, L., Jia, H., & Zhao, R. C. (2007) · Haematologica · doi:10.3324/haematol.10669 · Cited by 339
Mimeault, M., & Batra, S. K. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0066 · Cited by 285
Wysoczynski, M., Reca, R., Ratajczak, J., Kucia, M., Shirvaikar, N., Honczarenko, M., Mills, M., Wanzeck, J., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2005) · Blood · doi:10.1182/blood-2004-04-1430 · Cited by 252
Metadata
- Authors
- Kushida, T., Inaba, M., Hisha, H., Ichioka, N., Esumi, T., Ogawa, R., Iida, H., & Ikehara, S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2001-05-15
- Volume
- 97
- Issue
- 10
- Pages
- 3292-3299
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2088236916
- Cited by
- 264
- References
- 18
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intra–bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. https://app.cochat.ai/papers/10.1182/blood.v97.10.3292
- The paper
- Kushida, T., Inaba, M., Hisha, H., Ichioka, N., Esumi, T., Ogawa, R., Iida, H., & Ikehara, S. (2001). Intra–bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood. https://doi.org/10.1182/blood.v97.10.3292
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.